The firm produces its propriety ingredient Reducol, a blend of plant sterols and plant stanols.
Technology for extracting a plant sterol and stanol blend from tall oil pitch has been patented in the United States by Forbes Medi-Tech Corp. (Kearny, NJ). The company is a division of ingredients supplier Pharmachem Laboratories Inc. (Kearny, NJ). Forbes specializes in plant sterol/stanol technologies for healthy cholesterol management. The firm produces its propriety ingredient Reducol, a blend of plant sterols and plant stanols.
“This patent in the U.S. validates the many years of research and development by the dedicated team of scientists and engineers behind the development of our plant sterol–based technologies,” said Forbes senior vice president of operations Laura Wessman. “This patent further strengthens our ability to broadly protect our proprietary technology as we develop heart-healthy functional food and dietary supplement applications.”
Reducol is derived from coniferous, or evergreen, trees. The trees are processed, forming a tall oil pitch, from which the sterol/stanol blend is then extracted. Reducol works by blocking the absorption of some of the cholesterol from the intestine and into the body. The company says it has been clinically proven to significantly lower LDL cholesterol-up to 15.5% compared to control. The firm says that unlike competing ingredients that generally must be used in oil-based foods, Reducol can be used in a broader range of food products.
The new Forbes patent is #8,338,564.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.